Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Evaluation of Panitumumab and Gemcitabine as Treatment for Women With Recurrent Epithelial Ovarian Cancer.

NCT01296035 is registered in ClinicalTrials.gov with Women and Infants Hospital of Rhode Island as lead sponsor.

NCT NCT01296035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01296035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Evaluation of Panitumumab and Gemcitabine as Treatment for Women With Recurrent Epithelial Ovarian Cancer.
Lead sponsor
Women and Infants Hospital of Rhode Island
Phase
Phase 2
Overall status
Terminated
Start date
February 28, 2011
Completion date
November 30, 2013
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fallopian tube cancer, ovarian cancer, primary peritoneal cancer